Jan W. Vrijbloed

Biomarkers of sarcopenia in clinical trials—recommendations from the International Working Group on Sarcopenia

Matteo Cesari, Roger A. Fielding, Marco Pahor et al. · Journal of Cachexia Sarcopenia and Muscle · 2012 · 293 citations · Full text

Medicine, Geriatric Medicine, Geriatrics +16

Using a β‐Hairpin To Mimic an α‐Helix: Cyclic Peptidomimetic Inhibitors of the p53–HDM2 Protein–Protein Interaction

Rudi Fasan, Ricardo L. A. Dias, Kerstin Moehle et al. · Angewandte Chemie International Edition · 2004 · 180 citations

Medicine, Oncology, Pharmacology +16

Crystal Structure of OxyB, a Cytochrome P450 Implicated in an Oxidative Phenol Coupling Reaction during Vancomycin Biosynthesis

Katja Zerbe, Olena Pylypenko, Francesca Vitali et al. · Journal of Biological Chemistry · 2002 · 163 citations · Full text

Life Sciences, Biochemistry, Microbiology +13

Targeted Disruption of the <i>kstD</i> Gene Encoding a 3-Ketosteroid Δ ¹ -Dehydrogenase Isoenzyme of <i>Rhodococcus erythropolis</i> Strain SQ1

Robert van der Geize, G. I. Hessels, R. van Gerwen et al. · Applied and Environmental Microbiology · 2000 · 136 citations · Full text

Life Sciences, Microbiology, Molecular Genetics +10

C-terminal Agrin Fragment as a potential marker for sarcopenia caused by degeneration of the neuromuscular junction

Michael Drey, Cornel Sieber, Jürgen M. Bauer et al. · Experimental Gerontology · 2012 · 127 citations

Medicine, Cell Biology, Neurology +11